Registered entities
ABSCI CORP
Reg. No. 1672688United States
Absci, Llc
Reg. No. 453931977United States
Absci Corporation
Reg. No. 6940491United States
Absci Corporation
Reg. No. 853383487United States
Innovation
37 patent families (8 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace accelerating. Cited 2,771 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 17 |
| 2024 | 20 |
| 2025 | 21 |
| 2026 | 2 |
Social engagement
Social engagement: 19.9K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
24 investors on record; lead investors include Phoenix Venture Partners, KBI Biopharma, JSR Life Sciences, Casdin Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 54% |
| Private equity | 2 | 8% |
| Angel & family office | 1 | 4% |
| Accelerator & incubator | 1 | 4% |
| Other / undisclosed | 7 | 29% |
Hiring activity
Hires periodically
4 roles tracked across 3 of the last 12 months
3 Mar 2026 · Associate Director, Pharmacology & Bioassays · Vancouver
16 Jan 2026 · Senior Research Associate · Vancouver
9 Nov 2025 · Network Engineer · Vancouver
Based on job postings tracked across public sources.